ArticleBMC public health2025
Efficacy of an app for self-efficacy of patients with cancer through tailored information delivery and coaching: protocol for a randomized controlled trial.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundThough numerous mobile apps have been developed to support patients with cancer, there is no comprehensive app that integrates evidence-based medical information, schedule management, lifestyle modification tools, psychological support, and access to appropriate community resources, to address the needs of patients with cancer. This paper presents a protocol for a randomized controlled trial to evaluate the efficacy of a newly developed app designed specifically for patients with cancer.
methodsThis prospective, multicenter, matched-pairs, randomized control trial is designed to evaluate the efficacy of a digital app called Cancer Manager Plus (CAMA+) DISCUSSION: The app being evaluated is designed to be tailored to each user and provide information and services on four types of cancer, including evidence-based treatment information and appropriate mental and physical support according to the user's treatment stage. This app is the first to offer comprehensive features such as personalized information based on cancer type and treatment stage, mental and physical coaching, medication management and appointment scheduling, and links to appropriate resources related to wellness. This study will help understand how the app affects the self-efficacy of patients with cancer and type of adaptation to cancer, and assess the app's feasibility.
trial registrationThe clinical trial was registered with the Clinical Research Information Service, a part of the WHO International Clinical Trials Registry Platform, on March 5, 2024 (approval number: KCT0009219).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.